meta_pixel
Tapesearch Logo
Log in
The Curbsiders Internal Medicine Podcast

#113 Gout: Uric acid targets, urate lowering therapy, and random questions from social media

The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

Health & Fitness, Medicine, Science, Higher Education, Education

4.83.1K Ratings

🗓️ 10 September 2018

⏱️ 38 minutes

🧾️ Download transcript

Summary

Master the management of gout with tips from expert, Tuhina Neogi MD, PhD, Professor of Medicine at Boston University School of Medicine. Topics include: how to initiate and titrate urate lowering therapy, guidelines controversy over uric acid targets, colchicine & NSAIDS for anti-inflammatory prophylaxis, uricosuric agents, febuxostat, HLA B5801, use of uric acid levels in the acute setting and more random gout facts.

Full show notes available at http://thecurbsiders.com/podcast. Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at [email protected].

Credits:

  • Written and produced by: Matthew Watto MD
  • Hosts: Paul Williams MD, Stuart Brigham MD, Matthew Watto MD
  • Guest: Tuhina Neogi MD, PhD

Time Stamps

  • 00:00 Intro and guest bio
  • 01:30 Allopurinol initiation and titration
  • 07:10 Uricosuric therapy
  • 09:10 Controversy over uric acid targets for gout
  • 17:40 Parachutes and randomized controlled trials
  • 19:15 Colchicine or NSAIDS for prophylaxis
  • 23:20 Who needs febuxostat?
  • 26:20 When to refer for gout, HLA B5801, and checking uric acid levels in the acute setting
  • 33:29 Take home points
  • 36:15 Outro

Tags: allopurinol, uric, urate, acid, level, therapy, management, gout, flare, crystal, arthritis, titration, probenecid, febuxostat, target, acr, acp, guidelines, nsaids, colchicine, hla b5801, septic, rheumatology, assistant, care, doctor, education, family, FOAM, FOAMim, FOAMed, health, hospitalist, hospital, internal, internist, meded, medical, medicine, nurse, practitioner, professional, primary, physician, resident, student

Transcript

Click on a timestamp to play from that location

0:00.0

The first time I've got this is for entertainment education and information purposes only.

0:09.2

And the topics discussed should not be used only by industry, your ordinance, and these

0:11.5

are more than used in the same expressed on the spot, as far as I know those, should not be

0:14.1

interpreted perfectly for official policy or position of agency, the psychro-possibly,

0:16.0

cash-like morons will end affiliate outreach programs, and indeed there are any in fact

0:18.4

there are none. Pretty much we are responsible for this throughout, but we should always do

0:20.2

our homework and let's know when we're ready.

0:30.3

Welcome back to the Curb Siders. This is going to be a very quick introduction. Back again,

0:40.9

this week is Dr. Tahina Nioji. She is a rheumatologist and epidemiologist with a specialization

0:47.1

in Gout and osteoarthritis. She is currently leading updates of the American College of

0:53.3

Rheumatology Treatment Guidelines for both osteoarthritis and in Gout. Of course, on this episode we'll

0:59.2

be talking about Gout. This one, as I said prior, focuses more on urate lowering therapy.

1:06.0

What's the controversy about there? Should we be targeting urate levels? And then at the end of

1:11.1

the episode, the last 10, 15 minutes or so, we get into all your random questions from social media.

1:17.4

This episode is filled with great pearls. So without further delay, here is the rest of our

1:23.2

discussion with Dr. Tahina Nioji. So a question that had come up is, can you ever use alopeurinol

1:33.5

during this acute flare? Let's say this is not Mr. T's first acute flare. Let's say it's his

1:40.6

third one in a one-year period. When would you initiate alopeurinol? And so now we're sort of,

1:49.9

and how does that factor in, how does this factor into your analogy? So we just talked about the

1:53.4

stuff to put out the fire, right? Now we're talking about the bathtub analogy. So can you kind of

1:59.0

walk us through? Yeah, so this is a really great question, very clinically important. And I think if

2:07.0

you ask different people, it'll get different opinions because we don't actually have great data

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Curbsiders Internal Medicine Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Curbsiders Internal Medicine Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.